Germany's Bavaria Plans to Buy Sputnik V Vaccine
Click the image below to enlarge the infographic.
- Germany's Bavaria region has struck a deal with the Russian government to acquire doses of the Sputnik V COVID-19 vaccine once it is approved by European drug regulators
- The southern state has signed a letter of intent to purchase up to 2.5 million doses of the vaccine if approved by the European Medicines Agency, the regional health ministry said Wednesday
- In addition to the option of importing the vaccines from Russia, a production facility is also to be set up by the drugmaker R-Pharm in the town of Illertissen, the ministry added
- The EMA has launched a review of the Sputnik V vaccine, in a key step towards approving the vaccine, which would become the first non-Western coronavirus vaccine to be used across the bloc
- Reviews of the Sputnik V vaccine have been largely positive, with leading medical journal, The Lancet, publishing results showing that the vaccine is more than 90% effective